J Korean Med Sci.  2009 Aug;24(4):751-754. 10.3346/jkms.2009.24.4.751.

Phenotypic and Genotypic Correction of WASP Gene Mutation in Wiskott-Aldrich Syndrome by Unrelated Cord Blood Stem Cell Transplantation

Affiliations
  • 1Department of Pediatrics and Hematopoietic Stem Cell Transplantation Center, Hanyang University College of Medicine, Seoul, Korea. pedonco@hmc.hanyang.ac.kr
  • 2Department of Microbiology, Chungnam University College of Medicine, Daejeon, Korea.
  • 3Department of Pediatrics, Dong-A University College of Medicine, Busan, Korea.

Abstract

We present two cases of Wiskott-Aldrich syndrome (WAS), in which nonsense mutations in the WASP gene were corrected phenotypically as well as genotypically by unrelated cord blood stem cell transplantation (CBSCT). Two male patients were diagnosed with WAS at the age of 5-month and 3-month and each received unrelated CBSCT at 16-month and 20-month of age, respectively. The infused cord blood (CB) units had 4/6 and 5/6 HLA matches and the infusion doses of total nucleated cells (TNC) and CD34+ cells were 6.24x10(7)/kg and 5.08x10(7)/kg for TNC and 1.33x10(5)/kg and 4.8x10(5)/kg for CD34+ cells, for UPN1 and UPN2, respectively. Complete donor cell chimerism was documented by variable number tandem repeat (VNTR) with neutrophil engraftment on days 31 and 13 and platelets on days 58 and 50, respectively. Immunologic reconstitution demonstrated that CBSCT resulted in consistent and stable T-, B-, and NK-cell development. Flow cytometric analysis for immunologic markers and sequence analysis of the WASP gene mutation revealed a normal pattern after CBSCT. These cases demonstrate that CBs can be an important source of stem cells for the phenotypical and genotypical correction of genetic diseases such as WAS.

Keyword

Wiskott-Aldrich Syndrome; WASP; Unrelated Cord Blood Stem Cell Transplantation

MeSH Terms

*Cord Blood Stem Cell Transplantation
Follow-Up Studies
Genotype
HLA Antigens/immunology
Humans
Infant
Male
Mutation
Phenotype
Sequence Analysis
Wiskott-Aldrich Syndrome/diagnosis/genetics/*therapy
Wiskott-Aldrich Syndrome Protein/*genetics

Figure

  • Fig. 1 Sequence analysis showing genetic correction of the WASP gene in UPN 1. DNA sequences are shown that encompass a single point mutation (C to T) or a correction in exon 7 of the WASP gene. The asterisk denotes a C to T transversion or the T to C correction.


Reference

1. Ochs HD, Rosen FS. Ochs HD, Edvard Smith CI, Puck JM, editors. The Wiskott-Aldrich syndrome. Primary Immunodeficiency Diseases. 1999. New York, NY: Oxford University Press;292–305.
2. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of Wiskott-Aldrich syndrome. J Pediatr. 1994. 125:876–885.
3. Snapper SB, Rosen FS. The Wiskott-Aldrich syndrome Protein (WASP): roles in signaling and cytoskeletal organization. Annu Rev Immunol. 1999. 17:905–929.
Article
4. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994. 78:635–644.
Article
5. Greer WL, Shehabeldin A, Schulman J, Junker A, Siminovitch KA. Identification of WASP mutations, mutation hotspots and genotype-phenotype disparities in 24 patients with the Wiskott-Aldrich syndrome. Hum Genet. 1996. 98:685–690.
Article
6. Kwan SP, Hagemann TL, Blaese RM, Knutsen A, Rosen FS. Scanning of Wiskott-Aldrich syndrome (WAS) gene: identification of 18 novel alterations including a possible mutation hotspot at Arg86 resulting in thrombocytopenia, a mild WAS phenotype. Hum Mol Genet. 1995. 4:1995–1998.
7. Wengler GS, Notarangelo LD, Berardelli S, Pollonni G, Mella P, Fasth A, Ugazio AG, Parolini O. High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood. 1995. 86:3648–3654.
Article
8. Zhu Q, Zhang M, Blaese RM, Derry JM, Junker A, Francke U, Chen SH, Ochs HD. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood. 1995. 86:3797–3804.
Article
9. Zhu Q, Watanabe C, Liu T, Hollenbaugh D, Blaese RM, Kanner SB, Aruffo A, Ochs HD. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood. 1997. 90:2680–2689.
Article
10. Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, Yata J, Mizutani S, Ochs HD, Nonoyama S. Clinical course of patients with WASP gene mutations. Blood. 2004. 103:456–464.
Article
11. Kernan NA, Schroeder ML, Ciavarella D, Preti RA, Rubinstein P, O'Reilly RJ. Umbilical cord blood infusion in a patient for correction of Wiskott-Aldrich syndrome. Blood Cells. 1994. 20:245–248.
12. Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ, Casper JT, Cowan MJ, Edwards JR, Fasth A, Gale RP, Junker A, Kamani NR, Loechelt BJ, Pietryga DW, Ringdén O, Vowels M, Hegland J, Williams AV, Klein JP, Sobocinski KA, Rowlings PA, Horowitz MM. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001. 97:1598–1603.
13. Yamaguchi K, Ariga T, Yamada M, Nelson DL, Kobayashi R, Kobayashi C, Noguchi Y, Ito Y, Katamura K, Nagatoshi N, Kondo S, Katoh H, Sakiyama Y. Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression. Blood. 2002. 100:1208–1214.
Article
14. Knutsen AP, Steffen M, Wassmer K, Wall DA. Umbilical cord blood transplantation in Wiskott-Aldrich syndrome. J Pediatr. 2003. 142:519–523.
15. Slatter MA, Bhattacharya A, Flood TJ, Abinun M, Cant AJ, Gennery AR. Use of two unrelated umbilical cord stem cell units in stem cell transplantation for Wiskott-Aldrich syndrome. Pediatr Blood Cancer. 2006. 47:332–334.
Article
16. Kobayashi R, Ariga T, Nonoyama S, Kanegane H, Tsuchiya S, Morio T, Yabe H, Nagatoshi Y, Kawa K, Tabuchi K, Tsuchida M, Miyawaki T, Kato S. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan. Br J Haematol. 2006. 135:362–366.
Article
17. Jo EK, Futatani T, Kanegane H, Kubota T, Lee YH, Jung JA, Song CH, Park JK, Nonoyama S, Miyawaki T. Mutational analysis of the WASP Gene in 2 Korean families with Wiskott-Aldrich syndrome. Int J Hematol. 2003. 78:40–44.
18. Sasahara Y, Kawai S, Kumaki S, Ohashi Y, Minegishi M, Tsuchiya S. Novel mutations, no detectable mRNA and familial genetic analysis of the Wiskott-Aldrich syndrome protein gene in six Japanese patients with Wiskott-Aldrich syndrome. Eur J Pediatr. 2000. 159:23–30.
Article
19. Knutsen AP, Wall DA. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders. J Allergy Clin Immunol. 1999. 103:823–832.
Article
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr